Royal Bank Of Canada reaffirmed their buy rating on shares of K2M Group Holdings, Inc. (NASDAQ:KTWO) in a report published on Friday morning. Royal Bank Of Canada currently has a $26.00 price objective on the medical device company’s stock.

Other analysts also recently issued reports about the stock. Oppenheimer Holdings, Inc. reaffirmed a buy rating on shares of K2M Group Holdings in a report on Thursday, June 22nd. BidaskClub raised shares of K2M Group Holdings from a hold rating to a buy rating in a report on Wednesday, July 19th. Cowen and Company reaffirmed a buy rating and issued a $26.00 price objective on shares of K2M Group Holdings in a report on Wednesday, July 19th. Needham & Company LLC reaffirmed a buy rating on shares of K2M Group Holdings in a report on Wednesday, August 2nd. Finally, Zacks Investment Research raised shares of K2M Group Holdings from a sell rating to a hold rating in a report on Saturday, August 5th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. K2M Group Holdings presently has a consensus rating of Buy and an average target price of $27.14.

Shares of K2M Group Holdings (KTWO) traded up 0.24% on Friday, hitting $20.85. 393,177 shares of the stock traded hands. The stock has a 50 day moving average of $22.95 and a 200 day moving average of $22.37. K2M Group Holdings has a one year low of $16.32 and a one year high of $25.99. The company’s market cap is $902.14 million.

K2M Group Holdings (NASDAQ:KTWO) last released its quarterly earnings data on Tuesday, August 1st. The medical device company reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.01. The business had revenue of $65.70 million for the quarter, compared to the consensus estimate of $66.26 million. K2M Group Holdings had a negative net margin of 16.21% and a negative return on equity of 15.45%. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.27) EPS. Equities analysts anticipate that K2M Group Holdings will post ($0.78) earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This piece was first posted by Daily Political and is the property of of Daily Political. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.dailypolitical.com/2017/09/23/k2m-group-holdings-inc-ktwo-receives-buy-rating-from-royal-bank-of-canada.html.

In related news, CFO Gregory S. Cole sold 2,350 shares of the stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total transaction of $56,588.00. Following the sale, the chief financial officer now directly owns 55,158 shares of the company’s stock, valued at $1,328,204.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider John Philip Md Kostuik sold 1,332 shares of the stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $23.30, for a total transaction of $31,035.60. Following the sale, the insider now directly owns 200,629 shares in the company, valued at $4,674,655.70. The disclosure for this sale can be found here. Insiders have sold 45,085 shares of company stock worth $1,056,903 over the last three months. 5.80% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. TimesSquare Capital Management LLC boosted its holdings in K2M Group Holdings by 31.5% during the second quarter. TimesSquare Capital Management LLC now owns 2,888,020 shares of the medical device company’s stock worth $70,352,000 after buying an additional 691,000 shares in the last quarter. Wellington Management Group LLP boosted its holdings in K2M Group Holdings by 10.4% during the first quarter. Wellington Management Group LLP now owns 1,875,913 shares of the medical device company’s stock worth $38,475,000 after buying an additional 175,998 shares in the last quarter. Schroder Investment Management Group boosted its holdings in K2M Group Holdings by 1.6% during the second quarter. Schroder Investment Management Group now owns 1,560,340 shares of the medical device company’s stock worth $37,401,000 after buying an additional 24,671 shares in the last quarter. Vanguard Group Inc. boosted its holdings in K2M Group Holdings by 12.4% during the second quarter. Vanguard Group Inc. now owns 1,550,592 shares of the medical device company’s stock worth $37,772,000 after buying an additional 171,502 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in K2M Group Holdings by 54.3% during the first quarter. JPMorgan Chase & Co. now owns 1,409,360 shares of the medical device company’s stock worth $28,906,000 after buying an additional 495,749 shares in the last quarter. 97.86% of the stock is currently owned by hedge funds and other institutional investors.

About K2M Group Holdings

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Analyst Recommendations for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.